Alzheimer’s drug development
The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical
Researchers at Yale School of Medicine have discovered a new drug compound that reverses the
Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts
“If these results are replicated in Alzheimer’s disease patients, it would open up a promising